Omicron to infect more than half of Europe's population in 6-8 weeks - WHO
Europe saw more than 7 million newly-reported cases in the first week of 2022, more than doubling over a two-week period, WHO's Europe director Hans Kluge told a news briefing.
"At this rate, the Institute for Health Metrics and Evaluation forecasts that more than 50% of the population in the region will be infected with Omicron in the next 6-8 weeks," Kluge said, referring to a research centre at the University of Washington.Fifty out of 53 countries in Europe and central Asia have logged cases of the more infectious variant, Kluge said.
Evidence, however, is emerging that Omicron is affecting the upper respiratory tract more than the lungs, causing milder symptoms than previous variants.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
How quickly do omicron symptoms appear? What’s the incubation period?Omicron symptoms can appear quicker than other variants of COVID-19.
Read more »
Nearly 25% of hospitalized patients in North Texas have COVID-19About one in four patients hospitalized in North Texas have COVID-19, as the highly-contagious omicron variant continues to spread throughout Dallas-Fort...
Read more »
Pfizer: Omicron-specific COVID-19 vaccine human trials to begin late JanuaryPfizer confirmed it plans to start human trials of its omicron-specific COVID-19 vaccine later this month, potentially making it available to the public as soon as March.
Read more »
California surpasses astonishing 6 million COVID-19 infections as Omicron wave expandsThe arrival of Omicron has pushed daily caseloads to their highest levels and sent a stream of new coronavirus-positive people to the hospital.
Read more »
U.S. breaks COVID-19 hospitalization record at over 132,000 as Omicron surgesCOVID-19 hospitalizations in the United States reached a record high on Monday, according to a Reuters tally, as a surge in infections caused by the highly contagious Omicron variant strains health systems in several states.
Read more »
Avacta pauses sales of COVID-19 antigen test to improve Omicron sensitivityBritain's Avacta Group is halting sales of its COVID-19 rapid antigen lateral flow test to replace antibodies in the device and boost its ability to detect the Omicron variant, the biotech firm said on Monday, sending its shares plunging nearly 27%.
Read more »